WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 5 fonti

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.

Raccontata danpr.orgnbcnews.comansa.itforbes.commedpagetoday.com

Confronto fonti

5 prospettive sulla stessa storia
AI · summaries
npr.orgStai leggendo1 mesi fa

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.

originale

Timeline cronologica

  1. lunedì 1 giugno 2026·npr.org

    A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

    A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.

  2. lunedì 1 giugno 2026·nbcnews.com

    A personalized vaccine for melanoma cut the risk of cancer returning after five years

    If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.

nbcnews.com
1 mesi fa

A personalized vaccine for melanoma cut the risk of cancer returning after five years

If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.

Leggi questa versione → originale
forbes.com1 mesi fa

New Study Shows How mRNA Vaccines Could Transform Cancer Treatment

Personalized mRNA vaccines with immunotherapy achieved 70% five-year cancer-free survival in melanoma versus 49% immunotherapy alone. Tumor sequencing enables data-driven patient-specific vaccines, shifting cancer treatment from generic protocols to personalization across cancer types.

Leggi questa versione → originale
medpagetoday.com1 mesi fa

Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years

Adjuvant approach will need confirmation from ongoing phase III trial, says expert

Leggi questa versione → originale
ansa.it1 mesi fa

Melanoma, a 5 anni vivo il 92% dei pazienti trattato con il vaccino personalizzato - Focus Tumore news -…

Vaccino mRNA personalizzato contro melanoma: 92,2% sopravvivenza a 5 anni vs 71,3%, riduce del 59% il rischio metastasi. Il modello di genomic personalization si replicherà su polmone e tumori ad alta mutazione, trasformando precision medicine in standard terapeutico.

Leggi questa versione → originale
  • lunedì 1 giugno 2026·ansa.it

    Melanoma, a 5 anni vivo il 92% dei pazienti trattato con il vaccino personalizzato - Focus Tumore news - Ansa.it

    Dal congresso mondiale di oncologia ASCO in corso a Chicago arriva una importante conferma sull'efficacia del vaccino a mRna contro il melanoma, la cui sperimentazione è iniziata…

  • martedì 2 giugno 2026·forbes.com

    New Study Shows How mRNA Vaccines Could Transform Cancer Treatment

    A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer patients

  • martedì 2 giugno 2026·medpagetoday.com

    Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years

    Adjuvant approach will need confirmation from ongoing phase III trial, says expert